A compilation of documented data from 45 Africa malaria-endemic countries on the scale-up of malaria diagnostics and treatment
This report was commissioned by MMV and the RBM Partnership’s Procurement and Supply Chain Management working group in recognition of the Abuja targets and WHO recommendation for confirming diagnosis of malaria prior to treatment. It brings together documented data from 45 African malaria-endemic countries, up to October 2009, on the status of funding and estimated commodity needs in order to assure increased coverage of malaria diagnostics and treatment.
Three key findings of the report include:
- There is a need for a common definition of ‘universal coverage’ for artemisinin-based combination therapy (ACT) and rapid diagnostic test (RDT) scale-up;
- There is a need to address the current imbalance between ACT and RDT procurements – ACT estimates are currently significantly higher than RDT estimates. This is required in order to align with current WHO guidance on confirmed diagnosis before treatment;
- High-level political and resource investments are essential if we are to achieve appropriate coverage of correct case management where coverage stands at relatively low rates in many countries.
For further information, please contact Renia Coghlan (coghlanr [at] mmv.org)